10 Tips to Combat Coronavirus 10 Tips to Combat Coronavirus

ADVERTISEMENT

213 Women Who Took Gardasil Suffered Permanent Disability

Story at-a-glance -

  • A class-action lawsuit has been filed in Australia against drug maker Merck by a young woman who suffered autoimmune and neurological health problems following injections with the HPV vaccine, Gardasil
  • Multiple-sclerosis-like symptoms and neurological complications, including seizures, paralysis and speech problems, are being reported by increasing numbers of girls and women following Gardasil vaccination
  • Between May 2009 and September 2010, 16 deaths occurred after Gardasil vaccination, along with 789 reports of "serious" adverse reactions; 213 cases of permanent disability; and 25 cases of Guillain Barre Syndrome. Between September 1, 2010 and September 15, 2011, <i>yet another</i> 26 deaths were reported
  • There are more than 100 types of human papillomaviruses (HPVs) and Gardasil protects against only 4 types but 90 percent of women naturally clear HPV from their bodies within two years, at which point cervical cells return to normal
  • The cervical cancer death rate is very low in the United States (3 per 100,000), as this cancer is usually entirely curable when detected early enough through PAP screenings, which have reduced cervical cancer rates by 70 percent in the U.S. since PAP screens have become a routine part of women’s health care

By Dr. Mercola

Naomi Snell, a 28-year-old woman in Melbourne, Australia, is leading a class-action civil lawsuit against drug maker Merck after suffering autoimmune and neurological complications following injections with the HPV vaccine, Gardasil.


Read the Full Article for Free!
Subscribe to the #1 Natural Health Newsletter
  • Unlock censored health information that Google doesn't want you to read
  • Keep your privacy secure — We are no longer active on Facebook and are blocking our content from Google search to ensure your privacy stays protected
  • Get access to all of Dr. Mercola's health articles, E-books and special reports

Existing Subscribers: Enter your email address for instant access